Carlos Ghosn to Asharq Al-Awsat: I Will Seize Nissan’s Properties in Lebanon, the World

Carlos Ghosn speaks to Asharq Al-Awsat
Carlos Ghosn speaks to Asharq Al-Awsat
TT

Carlos Ghosn to Asharq Al-Awsat: I Will Seize Nissan’s Properties in Lebanon, the World

Carlos Ghosn speaks to Asharq Al-Awsat
Carlos Ghosn speaks to Asharq Al-Awsat

Former Chairman of the Board of Nissan Carlos Ghosn said he was serious in suing the company “to compensate for the moral and physical abuse he suffered as a result of his arrest in Japan,” hinting at seeking to seize Nissan’s property in Lebanon and the world.

In an interview with Asharq Al-Awsat, Ghosn denied local “political support” or an intention to work in politics.

Ghosn maintains the theory of a “conspiracy” plotted against him, which he said was prepared a year before his arrest.

“On the same day, they stripped me of everything, prevented me from accessing information, entered my house... and took all the information they wanted,” he stated.

Recounting how he was arrested in Japan on charges of not declaring money that he did not receive in the first place, he said that when the authorities discovered that the case was groundless, plots began against him.

The former Nissan CEO justifies the reason for waiting so long to file the lawsuit, by saying: “It took a long time to re-investigate what happened and go into the details... because they stripped me of everything.”

He added that he assigned a team of lawyers to collect files and evidence that back his case.

According to Ghosn, the one billion dollars, which he is requesting as compensation from Nissan, is not a large amount compared to the damage and losses he has incurred.

He stressed that the company has distorted his reputation and future, because of the accusations launched against him.

“A billion dollars is a small compensation,” he underlined.

Ghosn said, however, that he was not surprised by the skeptical questions.

“Everyone is wondering: Can Japan do such a thing? Yes, in Japan there are many good things, but on the other hand there are bad things,” he told Asharq Al-Awsat, saying that the country “does not care about human rights.”

He explained that he chose Lebanon to file a lawsuit against Nissan, as he had to resort either to a Lebanese or a Japanese court.

“There must be a relationship between the crime and the country, and the two countries are either Japan or Lebanon, and I can only file a lawsuit in Lebanon,” he remarked.

Ghosn added that he would have preferred to resort to a court in the United States, should he have this option.

“I would have asked for $10 billion. These things do not happen in America. No one can behave with another person in this way in America... A billion dollars does not affect Nissan ... but $10 billion surely does.”

Ghosn stressed that if he won the case in Lebanon, he could seize Nissan’s properties in the country and elsewhere.

He explained that by virtue of international conventions, a foreign ruling can be enforceable in other countries.

“You can seize factories in America, for example, and the same applies in England, Spain, Egypt, Dubai and Brazil... The company cannot escape,” he said.

Ghosn ridiculed accusations against him of taking refuge in Lebanon “to escape justice.”

He affirmed that he came to Lebanon because he has interests, a home, and a family. He added that Lebanon was not the only country in the world that does not extradite its citizens, citing France and Brazil as an example.

“I did not run away, I fight because I have a right,” he told Asharq Al-Awsat.

The former CEO of Nissan strongly refuses to link his current lawsuit with an Interpol red notice for his arrest at France’s request, in a case of bribery involving a French minister.

He stressed that the accusations were unfounded, saying that they were politically-driven. He also expressed confidence that the French minister would win the lawsuit.

On a different note, Ghosn said he had no intention to work in politics in Lebanon, “but I can help politicians if needed.”

He added that he was moving freely in his country, “without fear”, as he does not feel threatened, noting that he was only taking some security precautions at the request of his children.

Ghosn stressed that he was currently focusing on the lawsuit against Nissan, as well as managing his business in Lebanon, especially after his property and investments were seized by the French authorities.

“The French put their hands on all my property, but the Japanese did not lay their hands on anything. My investments are only in Lebanon,” he stated.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.